PVLA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.39%

Insider Buying (Last 12 Months): $51,720.00

Insider Selling (Last 12 Months): $0.00

Palvella Therapeutics Insider Trading History Chart

Palvella Therapeutics Share Price & Price History

^$13.22

▼ -0.08 (-0.60%)

As of 01/16/2025 04:59 PM ET

Days: 30 | 90 | 365

Palvella Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/18/2024	George M Jenkins	Director	Buy	4,000	$12.93	$51,720.00	180,671

SEC Filings (Institutional Ownership Changes) for Palvella Therapeutics (NASDAQ:PVLA)

40.11% of Palvella Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Today's Range

Now: $13.22

$13.03

$13.63

50 Day Range

MA: N/A

52 Week Range

Now: $13.22

$6.20

$22.32

Volume

32,194 shs

Average Volume

48,519 shs

Market Capitalization

$17.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.67

Who are the company insiders with the largest holdings of Palvella Therapeutics?: Palvella Therapeutics' top insider investors include:
George M Jenkins (Director)
Learn More about top insider investors at Palvella Therapeutics.